Drug intelligence / Profile preview

methenolone

Development stage
Discontinued
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

**Methenolone** is a synthetic androgen and anabolic steroid (AAS) used primarily in the form of esters (metenolone acetate and metenolone enanthate) for the treatment of anemia due to bone marrow failure and conditions involving muscle wasting. The drug acts as an agonist of the androgen receptor, the biological target of androgens like testosterone and dihydrotestosterone (DHT), exhibiting moderate anabolic and weak androgenic effects. Methenolone itself is not commonly used therapeutically, as only its esters are marketed clinically. It has no estrogenic effects or risk of liver toxicity, and side effects primarily involve masculinization. Methenolone was developed in the late 1950s, mainly by Schering, and is mostly discontinued today, with most medical use now being in the form of its esters[3][2].

Brand names
PrimobolanPrimobolan DepotNibalNibal InjectionDelapromorPrimonabol depot
Other names
metenolone1-methyl-Δ1-androsten-17β-ol-3-oneAndrost-1-en-3-one 17-hydroxy-1-methyl-Androst1-en-3-one 17-hydroxy-1-methyl-Androst 1-en-3-one 17-hydroxy-1-methyl-17β-Hydroxy-1-methyl-5α-androst-1-en-3-one17-Hydroxy-1-methylandrost-1-en-3-oneMethenolonméténolone
02

Targets

SHBG (Sex hormone-binding globulin)AR (Adrenergic receptors)

Beyond the preview

Go deeper on methenolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methenolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call